Paula Annunziato - Info zur Person mit Bilder, News & Links



	Vice President FDA Merck Research Laboratories COVID-19 Manalapan Vaccines Clinical Research Health Merck's Ebola AMBLER

News

(1 - 4 von 16

–alle anzeigen

)

New vaccine cuts risk of painful shingles - Sarasota Herald ...

eu.heraldtribune.com

— People have the fear that anything they do may trigger it," said Paula Annunziato, a physician and official at Merck Research Laboratories, ... › story › news ›

News Scan for Jul 25, | CIDRAP

www.cidrap.umn.edu

... candidate forward in potentially meeting this public health need," said Paula Annunziato, MD, Merck's vice president for clinical research.

Women in Healthcare Equity Forum - EventBrowse.com

www.eventbrowse.com

... Dr. Paula Annunziato, Vice President of Global Clinical Development, Merck; Apoorva Mandavilli, Science and Global Health Reporter, The New York Times ...

FDA starts speedy review of Merck's Ebola vaccine - PMLiVEwww.pmlive.com › pharma_news › fda_starts_spee...

www.pmlive.com

· ... global public health preparedness and health security objectives,” said Paula Annunziato, vice president, Merck Research Laboratories.

Netzwerk-Profile

Facebook: Paula Annunziato

Facebook: Merck Careers - Women's History Month Spotlight: Paula Annunziatosw-ke.facebook.com › merckcareers › videos › wo...

About Susie S. de Paula Annunziato - Flickr

www.flickr.com

› people › ssdepaula

Interessen

(1 - 4 von 6

–alle anzeigen

)

Live Updates on FDA COVID-19 Vaccine Advisory Committee ...

www.businessinsider.com

— Dr. Paula Annunziato, who works in vaccine research at Merck is the non-voting industry representative, and Sheldon Toubman, a lawyer from ... › ...

15-Valent Pneumococcal Vaccine Shows Promise in Infants

www.medscape.com

— ... while maintaining immune responses to current vaccine serotypes to help sustain progress achieved to date," said Paula Annunziato, MD, ... › viewa...

FDA Accepts Merck’s Biologics License Application (BLA) and Grants...

www.businesswire.com

FDA Accepts Merck’s Biologics License Application and Grants Priority Review for V920, the Company’s Investigational Vaccine for Ebola Zaire Virus

Merck: FDA Grants Priority Review For Investigational Ebola Vaccinemarkets.businessinsider.com › news › stocks › merc...

markets.businessinsider.com

· ... global public health preparedness and health security objectives," said Paula Annunziato, vice president, Merck Research Laboratories.

Business-Profile

Paula Annunziato - Vice President & Ther.. - Merck - ZoomInfo

www.zoominfo.com

› Paula...

Private Homepages

Susie de Paula Annunziato - YouTube

www.youtube.com

› null

Bücher

Congenital Varicella-Zoster Virus Infection and Barrett's Esophagusur.booksc.eu › book

ur.booksc.eu

Congenital Varicella-Zoster Virus Infection and Barrett's Esophagus | Xilla T. Ussery, Paula Annunziato, Anne A. Gershon, Barbara S. Reid, Octavian Lungu, ...

FDA authorizes broad, flexible COVID-19 booster policy

rollcall.com

— ... lead to a successful vaccination program,” said Paula Annunziato, vice president of vaccine clinical development at Merck, last week. › fda-auth...

From the Hallowed Halls of Herpesvirology: A Tribute to Bernard...

books.google.de

We thank Anne and Mike Gershon, Paula Annunziato and Christos Panagiotidis for valuable advice and stimulating discussions. We also thank the laboratory of ...

Varicella-Zoster Virus: Molecular Biology, Pathogenesis, and ...

books.google.es

... were supported by grants AI and AI from the US Public Health Service to Anne Gershon and Saul Silverstein and Paula Annunziato, respectively.

Dokumente zum Namen

Profilaktyka krztuśca - Maria Mrozińska

www.mariamrozinska.pl

Paula Annunziato (Rochester. – USA) [12] objęła badaniem 172 zdrowych dzieci w wieku 4–6 lat, celem porównania reaktogenno- œci Infanrixu i DTPw.

TOP M A L E FINISHERS 5k R U N Place No. First Last City St Age ...

d368g9lw5ileu7.cloudfront.net

PAULA ANNUNZIATO 55 AMBLER PA 34: KATHLEEN SHAFER 57 NORTH WALES PA 34: DONNA WARGO ...

Wissenschaftliche Veröffentlichungen

Merck Begins Rolling Submission of Licensure AP Newsapnews.com › press-release › business-wire

apnews.com

... in accelerating the regulatory review process for V920,” said Paula Annunziato, M.D., vice president for clinical research, Merck Research Laboratories.

Ebola, malaria vaccines; HIV treatments expected in The East ...www.theeastafrican.co.ke › ... › Science & Health

www.theeastafrican.co.ke

· ... for the Ebola Zaire prior to licensure of the vaccine candidate,” said Paula Annunziato, Merck's vice-president for clinical research.

Veröffentlichungen allgemein

PROGRAMA - Fundadeps

fundadeps.org

Paula Annunziato. Vice President and TA Head, Vaccines. Global. Clinical Development Infectious Diseases/Vaccines: MSD USA. › › programacovid

Study finds West Africa at highest risk of bat-to-human Africa Health

africa-health.com

said Paula Annunziato, Merck's vice- president for clinical research. Trials of another Ebola vaccine called. VSV-Zebov are being conducted on.

Video & Audio

Paula Annunziato | C-SPAN.org

www.c-span.org

› person

Artikel & Meinungen

Women in Healthcare Equity Forum - All In Together

aitogether.org

Dr. Judy Absalon, Senior Medical Director of Vaccine Clinical Research, Pfizer; Dr. Paula Annunziato, Vice President of Global Clinical Development, Merck ... › women-in-...